Sialic acid moiety of apolipoprotein E and its impact on the formation of lipoprotein particles in human cerebrospinal fluid

Clinica Chimica Acta

Volumn 402, Issue 1-2, 2009, Pages 61-66

  Kawasaki, Kenji ^a   Ogiwara, Naoko ^a   Sugano, Mitsutoshi ^a   Okumura, Nobuo ^b   Yamauchi, Kazuyoshi ^a  

^a SHINSHU UNIVERSITY HOSPITAL   (Japan)

^b SHINSHU UNIVERSITY   (Japan)

Author keywords

ABEE; Alzheimer's disease; Apolipoprotein E; Cerebrospinal fluid; Sialic acid

Indexed keywords

APOLIPOPROTEIN E; BENZOCAINE; MANNOSAMINE; SIALIC ACID;

AGED; ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID LEVEL; CHILD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPOPROTEIN BLOOD LEVEL; PARTICLE SIZE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

AGE FACTORS; AGED; APOLIPOPROTEINS E; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; MALE; N-ACETYLNEURAMINIC ACID; PARTICLE SIZE;

EID: 60649095820     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.12.018     Document Type: Article

References (43)

1. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240 (1988) 622-630
2. Beisiegel U., Weber W., Ihrke G., Herz J., and Stanley K.K. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature 341 (1989) 162-164
3. Elshourbagy N.A., Liao W.S., Mahley R.W., and Taylor J.M. Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc Natl Acad Sci U S A 82 (1985) 203-207
4. Boyles J.K., Pitas R.E., Wilson E., Mahley R.W., and Taylor J.M. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest 76 (1985) 1501-1513
5. Pitas R.E., Boyles J.K., Lee S.H., Hui D., and Weisgraber K.H. Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E(LDL) receptors in the brain. J Biol Chem 262 (1987) 14352-14360
6. Pitas R.E., Boyles J.K., Lee S.H., Foss D., and Mahley R.W. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim Biophys Acta 917 (1987) 148-161
7. Roheim P.S., Carey M., Forte T., and Vega G.L. Apolipoproteins in human cerebrospinal fluid. Proc Natl Acad Sci U S A 76 (1979) 4646-4649
8. Miida T., Yamazaki F., Sakurai M., et al. The apolipoprotein E content of HDL in cerebrospinal fluid is higher in children than in adults. Clin Chem 45 (1999) 1294-1296
9. Yamauchi K., Tozuka M., Hidaka H., Hidaka E., Kondo Y., and Katsuyama T. Characterization of apolipoprotein E-containing lipoproteins in cerebrospinal fluid: effect of phenotype on the distribution of apolipoprotein E. Clin Chem 45 (1999) 1431-1438
10. Zannis V.I., Kurnit D.M., and Breslow J.L. Hepatic apo-A-I and apo-E and intestinal apo-A-I are synthesized in precursor isoprotein forms by organ cultures of human fetal tissues. J Biol Chem 257 (1982) 536-544
11. Zannis V.I., Breslow J.L., SanGiacomo T.R., Aden D.P., and Knowles B.B. Characterization of the major apolipoproteins secreted by two human hepatoma cell lines. Biochemistry 20 (1981) 7089-7096
12. Zannis V.I., McPherson J., Goldberger G., Karathanasis S.K., and Breslow J.L. Synthesis, intracellular processing, and signal peptide of human apolipoprotein E. J Biol Chem 259 (1984) 5495-5499
13. Schauer R. Sialic acids as antigenic determinants of complex carbohydrates. Adv Exp Med Biol 228 (1988) 47-72
14. Varki A. Sialic acids as ligands in recognition phenomena. FASEB J 11 (1997) 248-255
15. Munday J., Floyd H., and Crocker P.R. Sialic acid binding receptors (siglecs) expressed by macrophages. J Leukoc Biol 66 (1999) 705-711
16. Keppler O.T., Horstkorte R., Pawlita M., Schmidt C., and Reutter W. Biochemical engineering of the N-acyl side chain of sialic acid: biological implications. Glycobiology 11 (2001) 11R-18R
17. Kannagi R. Regulatory roles of carbohydrate ligands for selectins in the homing of lymphocytes. Curr Opin Struct Biol 12 (2002) 599-608
18. Crocker P.R. Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling. Curr Opin Struct Biol 12 (2002) 609-615
19. Guyton J.R., Miller S.E., Martin M.E., Khan W.A., Roses A.D., and Strittmatter W.J. Novel large apolipoprotein E-containing lipoproteins of density 1.006-1.060 g/ml in human cerebrospinal fluid. J Neurochem 70 (1998) 1235-1240
20. LaDu M.J., Gilligan S.M., Lukens J.R., Cabana V.G., Reardon C.A., Van Eldik L.J., and Holtzman D.M. Nascent astrocyte particles differ from lipoproteins in CSF. J Neurochem 70 (1998) 2070-2081
21. Namba Y., Tomonaga M., Kawasaki H., Otomo E., and Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 541 (1991) 163-166
22. Gunzburg M.J., Perugini M.A., and Howlett G.J. Structural basis for the recognition and cross-linking of amyloid fibrils by human apolipoprotein E. J Biol Chem 282 (2007) 35831-35841
23. Xu F., Vitek M.P., Colton C.A., et al. Human apolipoprotein E redistributes fibrillar amyloid deposition in Tg-SwDI mice. J Neurosci 28 (2008) 5312-5320
24. Strittmatter W.J., Saunders A.M., Schmechel D., et al. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 90 (1993) 1977-1981
25. LaDu M.J., Pederson T.M., Frail D.E., Reardon C.A., Getz G.S., and Falduto M.T. Purification of apolipoprotein E attenuates isoform-specific binding to β-amyloid. J Biol Chem 270 (1995) 9039-9042
26. Malek G., Johnson L.V., Mace B.E., et al. Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration. Proc Natl Acad Sci U S A 102 (2005) 11900-11905
27. 194 affects its interaction with β-amyloid(1-42) peptides. Clin Chim Acta 388 (2008) 123-129
28. Yamauchi Y., Deguchi N., Takagi C., et al. Role of the N- and C-terminal domains in binding of apolipoprotein E isoforms to heparan sulfate and dermatan sulfate: a surface plasmon resonance study. Biochemistry 47 (2008) 6702-6710
29. Yasuno S., Kokubo K., and Kamei M. New method for determining the sugar composition of glycoproteins, glycolipids, and oligosaccharides by high-performance liquid chromatography. Biosci Biotechnol Biochem 63 (1999) 1353-1359
30. Yamauchi K., Tozuka M., Nakabayashi T., et al. Apolipoprotein E in cerebrospinal fluid: relation to phenotype and plasma apolipoprotein E concentrations. Clin Chem 45 (1999) 497-504
31. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology, Q2 (R1) (2005)
32. Reardon CA, Driscoll DM, Davis RA, Borchardt RA, Getz GS. The charge polymorphism of rat apoprotein E. 1986;261:4638-4645.
33. Zanni E.E., Kouvatsi A., Hadzopoulou-Cladaras M., Krieger M., and Zannis V.I. Expression of ApoE gene in Chinese hamster cells with a reversible defect in O-glycosylation. Glycosylation is not required for apoE secretion. J Biol Chem 264 (1989) 9137-9140
34. Wernette-Hammond M.E., Lauer S.J., Corsini A., Walker D., Taylor J.M., and Rall Jr. S.C. Glycosylation of human apolipoprotein E. The carbohydrate attachment site is threonine 194. J Biol Chem 264 (1989) 9094-9101
35. Kakari S., Avgoustatos G., Ferderigos A.S., et al. Total and lipid-bound sialic acid in the cerebrospinal fluid of patients with brain tumors. Anticancer Res 4 (1984) 313-316
36. Hayakawa K., De Felice C., Watanabe T., et al. Determination of free N-acetylneuraminic acid in human body fluids by high-performance liquid chromatography with fluorimetric detection. J Chromatogr 620 (1993) 25-31
37. De Graaf T.W., Van der Stelt M.E., Anbergen M.G., and van Dijk W. Inflammation-induced expression of sialyl Lewis X-containing glycan structures on alpha 1-acid glycoprotein (orosomucoid) in human sera. J Exp Med 177 (1993) 657-666
38. Reganon E., Vila V., Martínez-Sales V., et al. Sialic acid is an inflammation marker associated with a history of deep vein thrombosis. Thromb Res 119 (2007) 73-78
39. Goswami K., and Koner B.C. Level of sialic acid residues in platelet proteins in diabetes, aging, and Hodgkin's lymphoma: a potential role of free radicals in desialylation. Biochem Biophys Res Commun 297 (2002) 502-505
40. Dousset N., Dousset J.C., Taus M., et al. Effect of desialylation on low density lipoproteins: comparative study before and after oxidative stress. Biochem Mol Biol Int 32 (1994) 555-563
41. Poirier J. Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease. Neurobiol Aging 26 (2005) 355-361
42. Bentley N.M., Ladu M.J., Rajan C., Getz G.S., and Reardon C.A. Apolipoprotein E structural requirements for the formation of SDS-stable complexes with β-amyloid-(1-40): the role of salt bridges. Biochem J 366 (2002) 273-279
43. Ladu M.J., Reardon C., Van Eldik L., Fagan A.M., Bu G., Holtzman D., and Getz G.S. Lipoproteins in the central nervous system. Ann N Y Acad Sci 903 (2000) 167-175